Clinical-stage immuno-oncology company Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has reported encouraging early response ...
Domain adaptation may be a novel creative solution to predict infection risk in patients with chronic lymphocytic leukemia ...
The Well News on MSN
Facing higher health care costs in 2026? Here's how to navigate coverage challenges
Health care costs in America can change as quickly as a diagnosis. One month, a treatment is manageable; the next, a coverage shift or a single high bill can make that same care feel out of reach.
As a world leader in the immuno-oncology field, Dr. Zihai Li has long been at the forefront of cancer immunotherapy.
Everyday Health on MSN
A daily drugstore multivitamin may slow biological aging
Taking a daily multivitamin for two years slowed biological aging by four months, based on several DNA-based biomarkers — but a healthy lifestyle still matters.
According to the Uganda Cancer Institute (UCI), several factors contribute to the high burden of oncologic emergencies in Uganda, with late diagnosis being among the most significant.
Aging is associated with increased risk for nearly every lung disease, including acute conditions like pneumonia and chronic diseases like chronic obstructive pulmonary disease, idiopathic pulmonary ...
Treatments for Alzheimer disease agitation, focal segmental glomerulosclerosis, hematological malignancies, HIV-1, and obesity are under review.
Imugene Limited (ASX: IMU), a clinical-stage immuno-oncology company developing immunotherapies, has announced promising results from its Phase 1b study of azer-cel, an off-the-shelf, allogeneic CAR T ...
When this happens, it can lead to autoimmune diseases such as rheumatoid arthritis, lupus, or aplastic anemia. Scientists have long wondered why this happens and why some people with blood cancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results